Advertisement

 

 

Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.

Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.
Author Information (click to view)

Grant M, Larijani M,


Grant M, Larijani M, (click to view)

Grant M, Larijani M,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

AIDS research and therapy 2017 09 1214(1) 44 doi 10.1186/s12981-017-0173-8

Abstract

APOBEC3G (A3G) and APOBEC3F (A3F) are DNA-mutating enzymes expressed in T cells, dendritic cells and macrophages. A3G/F have been considered innate immune host factors, based on reports that they lethally mutate the HIV genome in vitro. In vivo, A3G/F effectiveness is limited by viral proteins, entrapment in inactive complexes and filtration of mutations during viral life cycle. We hypothesized that the impact of sub-lethal A3G/F action could extend beyond the realm of innate immunity confined to the cytoplasm of infected cells. We measured recognition of wild type and A3G/F-mutated epitopes by cytotoxic T lymphocytes (CTL) from HIV-infected individuals and found that A3G/F-induced mutations overwhelmingly diminished CTL recognition of HIV peptides, in a human histocompatibility-linked leukocyte antigen (HLA)-dependent manner. Furthermore, we found corresponding enrichment of A3G/F-favored motifs in CTL epitope-encoding sequences within the HIV genome. These findings illustrate that A3G/F-mediated mutations mediate immune evasion by HIV in vivo. Therefore, we suggest that vaccine strategies target T cell or antibody epitopes that are not poised for mutation into escape variants by A3G/F action.

Submit a Comment

Your email address will not be published. Required fields are marked *

twenty − 5 =

[ HIDE/SHOW ]